Monoclonal antibody 'nirsevimab' highly effective in preventing severe RSV in infants, reducing hospitalisations and ICU ...

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...

Twelve more US children have died of influenza, surpassing the previous high for a flu season outside of a pandemic year, the ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Q1 2025 Earnings Call Transcript May 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.52, expectations ...

The US HHS has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with ...

Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

On May 1, the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced the ...